Tacrolimus exposure during pregnancy in kidney and liver transplantation recipients: A comparison between whole blood and plasma concentration‐to‐dose ratios
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70454 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Jildau R Meinderts und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Groningen Institute for Organ Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the…. Hauptthemen laut MEDLINE: Tacrolimus, Liver Transplantation, Immunosuppressive Agents, Kidney Transplantation. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aim
Tacrolimus monitoring is generally performed in whole blood (WB). Most (>85%) of circulating tacrolimus is bound to red blood cells. During pregnancy, WB monitoring might be suboptimal because of physiological changes including increased plasma volume and decreased haematocrit. Therefore, plasma tacrolimus monitoring might better indicate potential dosage needs in pregnant women.
Methods
This prospective single‐centre cohort study aimed to assess and compare tacrolimus WB and plasma concentration‐to‐dose (C/D) ratios before, during, and after pregnancy in kidney or liver transplant recipients. Linear mixed model analysis was used.
Results
Nine women with 10 pregnancies were included. Based on WB tacrolimus concentrations, the median prescribed dosage significantly increased from 3 pre‐pregnancy to 7.5 mg/day (+150%) in the third trimester ( p < .001). The correlation between plasma and WB tacrolimus concentrations decreased throughout pregnancy with a correlation coefficient of 0.70 in the first trimester, 0.41 in the second and 0.30 in the third trimester of pregnancy. Median WB tacrolimus C/D ratios significantly decreased from 1.48 pre‐pregnancy to 0.58 in the second and third trimester (−61%) (overall time effect p < .001). The effect of time became non‐significant after adjusting for haematocrit ( p = .40). Median plasma tacrolimus C/D ratios decreased from 0.03 pre‐pregnancy to 0.02 in the first trimester (−33%) and remained stable afterward (overall time effect p = 0.33) and was not affected by haematocrit.
Conclusion
Our findings suggest that increasing dosages targeting WB tacrolimus concentrations may not be necessary during pregnancy based on plasma tacrolimus concentrations. However, larger studies are needed to confirm the findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Groningen Institute for Organ Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Gastroenterology and Hepatology, Groningen Institute for Organ Transplantation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
- Department of Pharmaceutical Analysis, Groningen Research Institute for Pharmacy, University of Groningen, Groningen, the Netherlands.
ORCID-Profile: Jildau R Meinderts, Paola Mian, Frederike G I van Vilsteren, Karien M H van de Wetering, Jelmer R Prins, Stefan P Berger, Margriet F C de Jong
Zitieren
APA
Meinderts, J. R., Mian, P., van Vilsteren, F. G. I., van de Wetering, K. M. H., Prins, J. R., Berger, S. P., Touw, D. J., & de Jong, M. F. C. (2026). Tacrolimus exposure during pregnancy in kidney and liver transplantation recipients: A comparison between whole blood and plasma concentration‐to‐dose ratios. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70454
Vancouver
Meinderts JR, Mian P, van Vilsteren FGI, van de Wetering KMH, Prins JR, Berger SP, et al. Tacrolimus exposure during pregnancy in kidney and liver transplantation recipients: A comparison between whole blood and plasma concentration‐to‐dose ratios. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70454
BibTeX
@article{Meinderts2026,
author = {Meinderts, Jildau R and Mian, Paola and van Vilsteren, Frederike G I and van de Wetering, Karien M H and Prins, Jelmer R and Berger, Stefan P and Touw, Daan J and de Jong, Margriet F C},
title = {Tacrolimus exposure during pregnancy in kidney and liver transplantation recipients: A comparison between whole blood and plasma concentration‐to‐dose ratios},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70454}
}
EUVIMED